Miriam Kidron Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Miriam Kidron.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Miriam Kidron. Miriam Kidron is Chief Technology Officer in ORAMED PHARMACEUTICALS INC. ($IGVL) and Chief Medical &Tech Officer in ORAMED PHARMACEUTICALS INC. ($IGVL) and Chief Scientific Officer in ORAMED PHARMACEUTICALS INC. ($IGVL) and Chief Technology Officer in ORAMED PHARMACEUTICALS INC. ($IGVL) and Director in ORAMED PHARMACEUTICALS INC. ($IGVL) and See Remarks in ORAMED PHARMACEUTICALS INC. ($IGVL).
Latest Insider Trading Transactions of Miriam Kidron
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2021 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 4.80 | 100,000 | 480,000 | 100,000 | |
Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 3.16 | 104,000 | 328,640 | 104,000 | |
Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | D | 3.16 | 104,000 | 328,640 | 0 | |
Feb 28 2019 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 3.16 | 104,000 | 328,640 | 104,000 | |
Feb 02 2018 | ORMP | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 8.14 | 47,000 | 382,580 | 47,000 | |
Aug 03 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Sell | S | 8.50 | 89,636 | 761,906 | 75,000 | 164.6 K to 75 K (-54.44 %) |
Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Option Exercise | A | 7.77 | 69,999 | 543,892 | 69,999 | |
Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Grant | A | 0.00 | 75,000 | 0 | 164,636 | 89.6 K to 164.6 K (+83.67 %) |
Apr 19 2017 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Scientific Of ... | Sell | S | 6.33 | 52,814 | 334,313 | 89,636 | 142.5 K to 89.6 K (-37.08 %) |
Dec 31 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 8.61 | 24,000 | 206,707 | 142,450 | 166.5 K to 142.5 K (-14.42 %) |
Dec 31 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 9.08 | 15,000 | 136,178 | 166,450 | 181.5 K to 166.5 K (-8.27 %) |
Dec 31 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 9.27 | 11,000 | 101,915 | 181,450 | 192.5 K to 181.5 K (-5.72 %) |
Feb 25 2015 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Grant | A | 0.00 | 79,848 | 0 | 192,450 | 112.6 K to 192.5 K (+70.91 %) |
Nov 17 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Grant | A | 0.00 | 9,788 | 0 | 112,602 | 102.8 K to 112.6 K (+9.52 %) |
Sep 12 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 8.44 | 8,699 | 73,401 | 102,814 | 111.5 K to 102.8 K (-7.80 %) |
Sep 12 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 8.40 | 23,000 | 193,260 | 111,513 | 134.5 K to 111.5 K (-17.10 %) |
Sep 08 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 9.41 | 8,301 | 78,112 | 134,513 | 142.8 K to 134.5 K (-5.81 %) |
Aug 01 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology O ... | Option Exercise | M | 0.01 | 142,814 | 1,714 | 0 | |
Aug 01 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology O ... | Buy | M | 0.01 | 142,814 | 1,714 | 142,814 | 0 to 142.8 K |
Apr 11 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | A | 12.45 | 47,134 | 586,818 | 47,134 | |
Apr 03 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | M | 0.01 | 137,300 | 1,648 | 142,814 | |
Apr 03 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Sell | S | 12.03 | 137,300 | 1,651,582 | 0 | 137.3 K to 0 (-100.00 %) |
Apr 03 2014 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Buy | M | 0.01 | 137,300 | 1,648 | 137,300 | 0 to 137.3 K |
May 03 2010 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Medical &Tech ... | Option Exercise | A | 0.49 | 864,000 | 423,360 | 5,939,360 | |
May 09 2008 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | See Remarks | Option Exercise | A | 0.54 | 864,000 | 466,560 | 864,000 | |
Aug 08 2007 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Director | Option Exercise | A | 0.45 | 850,000 | 382,500 | 850,000 |
Page: 1